Associate Professor, at COLLEGE OF PHARMACY, QASSIM UNIVERSITY, Saudi Arabia.
Dr. Sridevi Chigurupati, M.Pharm., Ph.D., AFMSA, FAGE, FIC, R.Ph (India), is an accomplished pharmaceutical scientist and educator specializing in medicinal chemistry and pharmacognosy. Currently, she serves as an Associate Professor at the College of Pharmacy, Qassim University, Saudi Arabia. With a rich academic and research background, she has made significant contributions to pharmaceutical sciences through her work in drug design, natural product chemistry, and pharmacological screening. Dr. Chigurupati has published extensively in high-impact journals and actively supervises postgraduate students in advanced research projects. She has received numerous prestigious awards recognizing her excellence in teaching and research. Her expertise in synthetic chemistry, molecular modeling, and biological activity evaluation has positioned her as a leading researcher in the field.
Professional Profile
Scopus
ORCID
Google Scholar
Education 🎓
Dr. Sridevi Chigurupati holds a Ph.D. in Pharmaceutical Sciences from Jawaharlal Nehru Technological University, Hyderabad, India (2006-2012). She earned her Master of Pharmacy in Medicinal Chemistry from Manipal College of Pharmaceutical Sciences, Manipal University (2003-2005), graduating with distinction as a college topper. Her Bachelor of Pharmacy degree was obtained from Nalanda College of Pharmacy, Osmania University (1998-2002), where she also secured first-class distinction. Her academic journey reflects her deep commitment to pharmaceutical sciences, leading to significant contributions in medicinal chemistry and drug research.
Experience đź’Ľ
Dr. Chigurupati has over 18 years of teaching and research experience in pharmaceutical sciences. She has served as an Associate Professor at Qassim University, Saudi Arabia (2018-present), and previously held academic positions at AIMST University, Malaysia (2013-2018), and Geethanjali College of Pharmacy, India (2007-2013). Her roles have encompassed teaching, supervising research students, and conducting groundbreaking studies in pharmaceutical chemistry. She has been instrumental in developing academic curricula, organizing workshops, and mentoring students for high-impact research publications.
Research Interests 🔬
Dr. Chigurupati’s research focuses on the synthesis and evaluation of novel chemical entities for various pharmacological activities. Her expertise includes in-vitro and in-vivo screening of new compounds, natural product chemistry, peptide synthesis, drug design, QSAR, and molecular modeling. She is particularly interested in antioxidant, anti-Alzheimer, antidepressant, anti-inflammatory, and antidiabetic studies. Her research also involves analytical techniques like UV, IR, NMR, and Mass Spectroscopy for evaluating synthesized and natural products.
Awards & Recognitions 🏆
Dr. Chigurupati has received several prestigious awards, including the “Best Research Project Award” from Qassim University (2023), “Best Woman Scientist Award” from Genesin of Educational Impressions (2023), and “Outstanding Woman Author of Research Paper Award” (2021). She also received the “Excellence in Teaching Award” (2021) and the “Best Oral Paper Presentation” award at an international conference (2021). Her previous accolades include the “Outstanding Woman in Health and Medical Sciences Award” (2018) and the “Q3 STAR Award” from AIMST University, Malaysia (2016). She has also secured multiple research grants for her innovative projects.
Top Noted Publications đź“–
Dr. Chigurupati has authored numerous peer-reviewed articles in high-impact journals. Some notable publications include:
1. Medicinal Chemistry & Drug Discovery
-
Synthesis of pyridin-3-yl-1,3,4-oxadiazole and 5-p-tolyl-1,3,4-oxadiazole derivatives
- Journal: Journal of Molecular Structure, 2025
- Authors: Bibi Fatima, Faiza Saleem, Uzma Salar, Muhammad Taha, K.M. Khan
- Focus: Antihyperglycemic, AChE/BuChE inhibition, antioxidant activities
-
Synthesis of novel indazole derivatives as inhibitors of diabetics II
- Journal: Journal of Molecular Structure, 2025
- Authors: Fatema al-Nasser, Muhammad Taha, Fazal Rahim, Shatha Ghazi Felemban, Vijayan Venugopal
- Focus: Diabetes treatment, molecular docking & simulation
-
Synthesis, bioactivity, and molecular docking of pyrazole-bearing Schiff bases
- Journal: Journal of Molecular Structure, 2025
- Authors: Lotfi M. Aroua, Ibrahim S. Alkhaibari, Fahad M. Alminderej, Hamdoon Abdelhamid Mohammed, Abdul-Hamid Hamid Mohammad Emwas
- Focus: Dual alpha-amylase & alpha-glucosidase inhibitors, antioxidants
-
Rhodanine-benzamides as potential α-amylase inhibitors and radical scavengers
- Journal: Molecular Diversity, 2024
- Authors: Samuel Attah Egu, Irfan Ali, K.M. Khan, Mohsin Ali, Muhammad Taha
- Focus: Enzyme inhibition, antioxidant properties
2. AI & Computational Studies
3. Pharmacology & Neurobiology
4. Electrocatalysis & Medicinal Chemistry
-
Review on electrocatalytic nitrate reduction to ammonia
- Journal: Ionics, 2024
- Authors: C.R. Santhosh, Sampath Chinnam, Gattumane Motappa Madhu, Sridevi Chigurupati, Ravi Sankannavar
- Focus: Advances in ammonia production via electrochemistry
-
Imidazo[1,2-a]pyridine derivatives as anticancer agents
- Journal: Archiv der Pharmazie, 2024
- Authors: Ankush Kumar, Vishakha Sharma, Tapan Behl, Sridevi Chigurupati, Monika K. Sachdeva
- Focus: Cancer drug discovery
Conclusion
Dr. Sridevi Chigurupati is highly suitable for Research for Excellence in Research awards based on her academic excellence, significant research contributions, successful grants, and global recognition. Strengthening her high-impact publications, international collaborations, and industry partnerships would further enhance her research profile and competitiveness for prestigious global research awards.